L-Tyrosine – Capsules

Ingredient Overview

L-Tyrosine is a naturally occurring amino acid first isolated in 1846 from the protein casein in cheese by chemist Justus von Liebig¹. Its name comes from the Greek word tyros meaning “cheese.” Chemically, L-tyrosine is one of the 20 standard α-amino acids that serve as building blocks of proteins¹. In the human body it is considered a non-essential or “conditionally essential” amino acid, meaning a healthy organism can normally synthesize it (from phenylalanine) under adequate nutritional conditions². L-Tyrosine is a white crystalline powder that is practically insoluble in water and has a slight bitterness³. Historically, L-tyrosine attracted scientific interest as the precursor to several important biological molecules (such as hormones and pigments) without any implication of health benefits or claims. Modern uses of L-tyrosine include its role as a component in dietary protein and its addition to certain nutritional supplements and specialized diets, especially in medical conditions like phenylketonuria (PKU) where tyrosine may need to be supplied externally¹. Importantly, no health or physiological benefits are asserted here – this overview focuses strictly on the scientific and regulatory facts.

Chemical Classification and Structure

L-Tyrosine (IUPAC: L-2-amino-3-(4-hydroxyphenyl)propanoic acid) is classified as a polar aromatic amino acid. It has the molecular formula C₉H₁₁NO₃ and a molar mass of about 181.19 g/mol³. Structurally, tyrosine consists of an α-amino group (–NH₂) and an α-carboxylic acid group (–COOH) attached to the same central (alpha) carbon, with a para-hydroxyphenyl side chain (a benzene ring with a hydroxyl group) specific to tyrosine. This side chain is what makes tyrosine an aromatic amino acid, similar to phenylalanine (which differs only by lacking the hydroxyl) and tryptophan. Tyrosine’s phenolic –OH group confers slight polarity, but at physiological pH the side chain is uncharged, so tyrosine is often categorized as a relatively hydrophobic, uncharged polar amino acid¹. The presence of the hydroxyl allows tyrosine residues in proteins to participate in specialized interactions like phosphorylation. In solid form, L-tyrosine appears as colorless to white crystals and is noted to decompose at temperatures above ~280 °C³. Its water solubility is quite low (~0.4 g/L at 20 °C)³, which is lower than many other amino acids due to the bulky aromatic ring. L-Tyrosine’s stereochemistry is the L-form (naturally occurring configuration in proteins); the enantiomer D-tyrosine also exists in nature in some bacterial peptides but is not used in human protein synthesis. As a functional group within proteins, the tyrosyl side chain can form hydrogen bonds and contributes to the UV absorbance of proteins due to its aromatic ring. Overall, L-tyrosine is structurally and chemically similar to phenylalanine, from which it is biosynthetically derived via a hydroxylation reaction¹.

Dietary Sources

As an amino acid, L-tyrosine is abundant in protein-containing foods. The general population obtains tyrosine primarily through dietary proteins. Animal proteins are particularly rich sources: for example, a 100 g portion of lean beef or chicken provides on the order of 1.1–1.3 g of tyrosine⁴. In practical terms, a grilled 6-ounce (170 g) steak can contain roughly 2.1 g of tyrosine⁴. Similarly, fish (such as salmon or cod), pork, and poultry each supply around 1.0–1.2 g of tyrosine per 100 g cooked weight⁴. Plant-based sources also contribute tyrosine: soy products are notable examples (firm tofu provides ~0.7 g per 100 g)⁴, and cooked legumes like white beans contain roughly 0.25–0.3 g per 100 g serving⁴. Nuts and seeds tend to have higher tyrosine density; for instance, roasted pumpkin seeds provide about 1.08 g per 100 g⁴. Dairy products are moderate sources: one cup (240 mL) of skim milk has only ~170 mg tyrosine, whereas 100 g of cheese can range from ~0.5–1 g depending on type (e.g. ricotta ~0.6 g/100 g)⁴. Because tyrosine can be synthesized in the body, there is no strict minimum dietary requirement for it alone in healthy individuals; however, nutritional guidelines often consider phenylalanine and tyrosine together. The World Health Organization (WHO) recommends a combined phenylalanine+tyrosine intake of about 25 mg per kg body weight per day for adults⁴. This corresponds to roughly 1.75 g per day for a 70 kg person, of which approximately half (12.5 mg/kg, ~0.875 g) might be fulfilled by tyrosine if phenylalanine supplies the rest⁴. In practice, a balanced diet easily provides this amount – for example, a single serving of many protein-rich foods can meet or exceed 0.5–1 g of tyrosine. It should be noted that while general diets furnish ample tyrosine, certain medical diets (such as the low-phenylalanine diet for PKU patients) use tyrosine-enriched formulas to ensure adequate levels, since those individuals cannot convert phenylalanine to tyrosine¹. Food processing can influence tyrosine content mainly by breaking down proteins: aged cheeses often develop distinct tyrosine crystals on their surface due to protein breakdown releasing tyrosine, visually indicating its high concentration in those foods (though these crystals are a texture feature rather than a nutritional enhancement).

Biochemical Role and Presence in the Body

In human biochemistry, L-tyrosine plays several fundamental roles without implying any health benefit. Primarily, it is incorporated into proteins – tyrosine residues are present in most proteins and can be crucial for protein structure and function (for example, they can be sites of phosphorylation in cell signaling proteins)¹. Beyond its structural role in proteins, tyrosine serves as a metabolic precursor for a variety of biomolecules. It is the starting substrate for the synthesis of the catecholamine neurotransmitters and hormones: L-tyrosine is enzymatically converted to L-DOPA, which is then decarboxylated to form dopamine, and further converted to norepinephrine (noradrenaline) and epinephrine (adrenaline)⁵. These conversions occur in neural tissues and the adrenal medulla, and they require cofactors such as vitamin B₆, folate, copper, and vitamin C for the respective enzymatic steps¹. Tyrosine is also a precursor for thyroid hormones. In the thyroid gland, two tyrosine-derived residues (monoiodotyrosine and diiodotyrosine) couple (with added iodine atoms) to form thyroxine (T₄) and triiodothyronine (T₃)⁵. Additionally, L-tyrosine is required for the production of the pigment melanin in skin and hair: the enzyme tyrosinase oxidizes tyrosine to DOPAquinone, initiating melanin synthesis. Other minor derivatives include trace amines (like tyramine, produced by decarboxylation of tyrosine) and certain tissue-specific biomolecules (for example, tyrosine is incorporated into enkephalins and other peptides). In terms of distribution, after dietary intake proteins are digested and tyrosine is absorbed in the small intestine via active transport systems shared with other neutral amino acids¹. The absorbed tyrosine circulates in the bloodstream (normal fasting plasma tyrosine levels are on the order of 50–100 µM) and is taken up into cells as needed. Tyrosine can cross the blood–brain barrier using the large neutral amino acid transporter, which it shares with phenylalanine, tryptophan, and others¹. This transport is competitive, meaning high levels of one amino acid can affect uptake of another. Once inside the brain, tyrosine contributes to neurotransmitter synthesis as noted. The body can endogenously produce tyrosine through hydroxylation of phenylalanine (an essential amino acid) by the hepatic enzyme phenylalanine hydroxylase, so under normal conditions tyrosine is not required in the diet. However, in PKU (where that enzyme is deficient), tyrosine cannot be synthesized and thus becomes an essential nutrient that must be obtained externally to prevent deficiency¹. Under typical conditions, the body maintains a steady supply: tyrosine from dietary proteins or internal synthesis is rapidly utilized in protein turnover and the creation of the above-mentioned compounds. It does not accumulate at high free concentrations in tissues, as any surplus tends to be metabolized or excreted promptly. Overall, tyrosine’s roles are as a versatile biochemical substrate and protein constituent, rather than having any direct therapeutic or stimulatory effect on its own.

Metabolism and Excretion

Excess or unused L-tyrosine is broken down through specific metabolic pathways. Tyrosine catabolism occurs mainly in the liver (and to some extent in other tissues) via a series of enzymatic steps that ultimately split the molecule into smaller units that can be used for energy. First, tyrosine is transaminated (by tyrosine aminotransferase) to form p-hydroxyphenylpyruvate. Subsequent steps include oxidation by p-hydroxyphenylpyruvate dioxygenase to homogentisic acid, and further enzymatic conversions (through maleylacetoacetate and fumarylacetoacetate intermediates) leading to the end products fumarate and acetoacetate⁶. Fumarate enters the tricarboxylic acid (TCA) cycle (and can contribute to gluconeogenesis), while acetoacetate can be converted to acetyl-CoA or ketone bodies. Because its degradation yields both a glucogenic substrate (fumarate) and a ketogenic substrate (acetoacetate), tyrosine is classified as both glucogenic and ketogenic⁶. Under normal physiology, this catabolic route disposes of tyrosine that is not needed for protein or neurotransmitter/hormone synthesis. Any nitrogen removed from tyrosine (in the transamination step) is converted to ammonia and then to urea in the liver for excretion. The carbon skeleton, as noted, enters central metabolic pathways. Excretion of tyrosine itself is minimal when metabolism is functioning properly – only trace amounts of free tyrosine appear in urine. However, some metabolites of tyrosine are excreted: for example, small quantities of homogentisic acid and p-hydroxyphenylacetate may be found in urine as normal metabolic byproducts. In metabolic disorders like alkaptonuria (a rare genetic condition affecting tyrosine breakdown), homogentisic acid builds up and is excreted in large amounts, but in healthy individuals that pathway proceeds to completion. The body’s handling of supplemental tyrosine has been studied: after an oral dose, L-tyrosine is absorbed and peaks in plasma typically within 1–2 hours, and then levels decline as it is taken up by tissues and metabolized. One pharmacokinetic study showed plasma tyrosine returning near baseline by about 8 hours post-dose². The plasma half-life of free tyrosine is on the order of a couple of hours (exact values depend on dose and individual metabolism), reflecting efficient uptake and utilization. Tyrosine is eliminated primarily via conversion to the aforementioned metabolites rather than being excreted unchanged. If extremely high doses are ingested such that metabolic capacity is exceeded, some tyrosine might appear in urine, but this is not typical at normal supplemental intakes. Overall, L-tyrosine is rapidly cleared from circulation by incorporation into proteins or catabolic processing. The enzymatic pathway for tyrosine disposal is vital – interruptions in this pathway can lead to accumulation of intermediates (as seen in certain inborn errors of metabolism), emphasizing that under normal conditions the body prefers to break tyrosine down fully. From a nutritional standpoint, tyrosine is efficiently used and any surplus is safely handled by routine metabolic processes, with the end products excreted as carbon dioxide (via energy metabolism) and urea (via nitrogen disposal).

Industrial Production Methods

Industrial production of L-tyrosine is achieved through several methods, developed over time to improve efficiency and purity while remaining neutral regarding any advantages. Traditional production routes included protein hydrolysis, where tyrosine was extracted from protein-rich materials (for example, casein or keratin) by acid or enzymatic breakdown of the proteins⁷. This method yields L-tyrosine along with other amino acids, but it can be costly and is dependent on animal or plant protein sources. Another approach is chemical synthesis: multi-step organic synthesis can produce racemic DL-tyrosine, which then requires resolution to isolate the L-isomer (since only L-tyrosine is used in biological systems). Chemical synthesis of tyrosine historically involved protecting-group strategies and reagents to build the aromatic amino acid structure, but it has drawbacks including lower optical purity (without additional resolution steps) and environmental considerations (use of harsh chemicals)⁸. Enzymatic synthesis is a more targeted method where precursor compounds (such as p-hydroxyphenylpyruvate) are converted to L-tyrosine using specific enzymes or whole-cell biocatalysts; this can achieve high enantioselectivity. However, by far the most prevalent modern method is microbial fermentation. In fermentation processes, microorganisms (often strains of Escherichia coli or Corynebacterium glutamicum that are genetically optimized) produce L-tyrosine from simple substrates like glucose. Leading amino acid manufacturers use fermentation at scale – for example, Ajinomoto Co. produces food-grade amino acids by fermenting plant-based carbohydrate feedstocks (such as glucose from corn), with no animal-origin inputs, to generate L-tyrosine in high yield⁹. Fermentation offers advantages in sustainability and purity: the microbial cells synthesize only the L-tyrosine isomer, eliminating the need for chiral resolution, and modern strains can accumulate tyrosine to high concentrations in the broth. Recent advancements in strain engineering and bioprocess optimization have dramatically increased tyrosine fermentation efficiency. Scientific reports have documented E. coli fermentation achieving titers over 100 g of L-tyrosine per liter of culture broth under optimized conditions⁸. After fermentation, the L-tyrosine is recovered and purified through filtration, crystallization, and drying steps to meet quality standards. Typical purity of supplement-grade or pharmaceutical-grade L-tyrosine is very high – specifications require around 99–101% purity on a dry weight basis³. For instance, a technical monograph might state that L-tyrosine (when dried) should assay at ≥99.0% L-tyrosine content, with minimal levels of any impurities³. Quality control in manufacturing includes verifying identity (e.g. by infrared spectroscopy), purity (often by HPLC or titration), and absence of contaminants (heavy metals, residual solvents, microbial contamination, etc.)³. Each production method has its considerations: protein hydrolysis is less common now due to cost and source limitations, chemical synthesis is used for research or non-food purposes when needed, and fermentation is the industry standard for food and supplement L-tyrosine due to its efficiency and the ability to label the product as naturally fermented. From a neutral standpoint, these processes ensure that the L-tyrosine available as an ingredient is of high purity and chemically identical to the L-tyrosine found in nature.

Regulatory and Historical Background

L-Tyrosine has been recognized in biochemistry since the 19th century, but its regulatory status as a supplement ingredient has evolved in more recent decades. In the European Union (EU), L-tyrosine is allowed for use in food supplements and fortified foods as a source of amino acid, without a specific daily intake limit set at the EU level (individual Member States may provide guidance values). However, any health claims about L-tyrosine’s physiological benefits are tightly regulated. Notably, in 2011 an application was made under Article 13(5) of the EU Nutrition and Health Claims Regulation for a claim that L-tyrosine contributes to normal dopamine synthesis. The European Food Safety Authority (EFSA) evaluated the science and concluded that a cause-and-effect relationship does exist between dietary L-tyrosine (as part of a protein-adequate diet) and normal catecholamine (dopamine) production¹⁰. Despite this scientific acknowledgment of tyrosine’s role, the European Commission did not authorize the claim for consumer use, reasoning that the general EU population already gets sufficient tyrosine from protein in the diet and that the claim could be misleading¹⁰. As a result, no health claims for L-tyrosine are approved in the EU, and any marketing of tyrosine supplements cannot legally attribute benefits like improved mood, stress response, or cognitive function to the ingredient. Regulatory authorities emphasize that tyrosine’s functions (e.g. as a precursor to neurotransmitters) are fulfilled under normal dietary conditions without need for supplementation in healthy individuals. On the safety front, EFSA’s experts have reviewed tyrosine in various contexts. In animal nutrition, L-tyrosine is an authorized feed additive (identification number 3c401) used to supplement diets for all animal species. EFSA’s Animal Feed Panel recently reassessed this use and found that L-tyrosine does not pose safety concerns to target animals, consumers of animal products, or the environment when used appropriately¹¹. They also noted that pure L-tyrosine is not irritating to skin or eyes in handling¹¹. This aligns with human safety assessments. In the United States, L-tyrosine is considered Generally Recognized As Safe (GRAS) as a nutrient or dietary supplement ingredient. It is listed in the U.S. Code of Federal Regulations (21 CFR §582.5920) as GRAS when used in accordance with good manufacturing practice¹². This means that, at the levels added to foods or taken as supplements, tyrosine is not expected to cause harm in the general population. Historically, tyrosine has been included in parenteral (IV) nutrition formulations as well, typically in modified soluble forms, indicating its accepted nutritional role. Overall, regulators treat L-tyrosine as a normal amino acid nutrient – it may be added to products, but any claims of health enhancement require rigorous evidence and explicit authorization (which none have received in the EU to date). From a historical perspective, the understanding of tyrosine’s importance emerged in the early 20th century through its identification in proteins and metabolic pathways, and it became part of infant formulas and medical foods by the mid-20th century. Today, its regulatory status is that of a nutritive substance, with oversight to ensure it is manufactured to high purity and used truthfully without unproven claims.

Safety and Recommended Dosages

L-Tyrosine is generally regarded as safe when consumed as part of protein in foods or in reasonable supplement amounts, with no intrinsic toxicity at typical doses. Common supplemental dosages on the market range from about 500 mg to 1500 mg per day, often divided into one or more doses. These amounts are in line with those naturally obtained from a high-protein diet. Some clinical studies have used higher short-term doses, for example on the order of 100–150 mg per kg of body weight per day (which is ~7–10 g/day for a 70 kg adult) to test physiological effects under stress². Such high doses, administered for brief periods (up to a few days or weeks), have not shown serious adverse effects in healthy subjects under research conditions. However, chronic intake of very large doses is not advised without medical supervision. Manufacturers and regulatory bodies often suggest an upper limit around 10–12 g per day, mainly due to insufficient evidence of safety beyond that – doses above ~12 g/day are not recommended by supplement makers². Toxicological data indicates a low acute toxicity for L-tyrosine. In animal studies, the oral LD₅₀ (median lethal dose) in rats is greater than 5 g per kg body weight, meaning rats given this very large dose did not reach a 50% mortality threshold¹³. This translates to an extremely wide safety margin; for comparison, a 70 kg human would theoretically have to ingest tens of grams at once to approach this territory, far above normal consumption. In a 13-week subchronic study, rats tolerated daily tyrosine intakes of several hundred mg/kg with no significant organ toxicity, establishing a No-Observed-Adverse-Effect Level (NOAEL) of about 600 mg/kg/day for male rats¹³. These data support that tyrosine itself is not intrinsically poisonous at nutritional doses. Side effects of tyrosine are rare at moderate intakes. Some individuals report mild gastrointestinal upset (e.g. nausea) at higher doses on an empty stomach. Tyrosine can also affect neurotransmitter levels, so transient effects like restlessness or headache are anecdotally noted in some cases. An important caution is its potential to trigger migraines in susceptible persons – tyrosine is a precursor to tyramine, a compound that can provoke migraine headaches in sensitive individuals, so people with migraine disorders are often advised to moderate tyrosine intake or supplements². Another caution involves the thyroid: because tyrosine is used to make thyroid hormones, those with hyperthyroidism (overactive thyroid) or Graves’ disease are typically warned against tyrosine supplementation, as it might theoretically further increase thyroid hormone levels². Indeed, L-tyrosine is contraindicated in such conditions by some medical guidelines. Similarly, tyrosine should not be combined with monoamine oxidase inhibitors (MAOI) medications. MAOIs plus high-tyrosine foods/supplements can lead to excessive tyramine (due to MAO inhibition), risking a hypertensive crisis (the so-called “cheese effect”)². While tyrosine itself is not tyramine, high tyrosine intake can elevate tyramine formation in the body when MAO is blocked. Therefore, individuals on MAOI antidepressants are advised to avoid tyrosine supplements. Apart from these specific interactions, no major adverse effects have been confirmed for L-tyrosine at supplemental doses in healthy adults. Regulatory evaluations have reinforced its safety: EFSA’s Panel on Nutrition concluded that typical supplemental intakes of tyrosine do not pose safety concerns for the general population, given its efficient metabolism and the body’s familiarity with the amino acid¹¹. The U.S. FDA’s GRAS status similarly reflects consensus that tyrosine used in foods is safe under intended conditions¹². It is worth noting that “safe” does not equate to “beneficial” – it simply means that consuming tyrosine in the amounts people normally would (through diet or supplements within recommended range) is not expected to cause harm. Recommended dosages for supplements typically fall in the 500 mg to 1 g per dose range (often before meals), and some protocols suggest taking it 1–3 times daily if needed, though these regimens are usually for experimental or specific uses (e.g. acute stress scenarios) and not general health enhancement. There is no official Nutrient Reference Value (NRV) or upper limit set by EFSA specifically for tyrosine. Users are advised to follow product instructions and consider total protein intake. In summary, L-tyrosine is a safe amino acid ingredient when used responsibly: it has a wide margin of safety, with well-characterized metabolism, and the main precautions involve certain medical conditions and drug interactions rather than inherent toxicity.

Conclusion

L-Tyrosine is a neutrally defined dietary amino acid with clear chemical, nutritional, and regulatory profiles. It is an aromatic amino acid found abundantly in common foods and synthesized by the human body from phenylalanine. Historically identified in the 19th century, tyrosine’s importance in protein structure and as a precursor to neurotransmitters, thyroid hormones, and melanin has been firmly established by biochemistry research. Industrially, it is produced to high purity, often by fermentation, for use in supplements and fortified products. From a regulatory perspective, L-tyrosine is treated as a normal nutrient – permitted in supplements but without any approved health claims in the EU. Scientific assessments by authorities like EFSA and FDA have determined that tyrosine, at levels consumed in foods or typical supplements, does not pose safety risks to consumers. However, its physiological roles are adequately met by a standard diet, and supplementation beyond that is not recognized to confer health advantages in healthy individuals. In line with this, no specific health claims are authorized for L-tyrosine in Europe. In conclusion, L-tyrosine can be viewed as a safe, well-characterized amino acid ingredient that contributes to protein nutrition and biochemical processes, but any assertions of health benefits remain unsubstantiated and are not permitted in marketing. Consumers and manufacturers must therefore focus on tyrosine’s factual scientific context without implying medical or functional claims.

This scientific overview has presented chemical, biochemical, and regulatory context without any health claims. The European Food Safety Authority (EFSA) has not approved any health or physiological claims associated with L-Tyrosine. Consumers should not interpret this educational information as medical advice or a basis for health decisions. Always consult a healthcare professional before starting dietary supplements or making significant dietary changes. Supplements should complement, not replace, a varied and balanced diet or a healthy lifestyle.

1. Drugs.com. (2024). Tyrosine – Clinical Overview and Monograph. (Medically reviewed Oct 31, 2024). Retrieved from https://www.drugs.com/npp/tyrosine.html

2. Jung, S. E., Hase, A., & van het Rot, M. (2015). Behavioral and cognitive effects of tyrosine intake in healthy human adults. Pharmacology Biochemistry and Behavior, 133, 1–6. https://doi.org/10.1016/j.pbb.2015.03.008

3. Ajinomoto Co., Inc. (2016). L-Tyrosine Specifications (Food/Pharma Grade). AminoScience Division Technical Sheet. (Spec#: 60-18-4, Issued Apr 8, 2016).

4. Whitbread, D., & Shelton, P. (2024). Top 10 Foods Highest in Tyrosine. MyFoodData (Evidence-based nutrition database). Updated November 10, 2024. Available from: https://www.myfooddata.com/articles/high-tyrosine-foods.php

5. Human Metabolome Database (HMDB). (2023). L-Tyrosine (HMDB0000158). In: Wishart, D.S. et al., The Human Metabolome Database 5.0. Retrieved from https://hmdb.ca/metabolites/HMDB0000158

6. Chemistry LibreTexts. (2025). Amino Acid Catabolism (Section 16.2). (K. Ahern & I. Rajagopal, eds.). LibreTexts Library, updated 2025. Available at: https://chem.libretexts.org (CC BY-NC-SA 4.0).

7. Chen, Z., Ma, L., Liu, W., et al. (2025). Systems metabolic engineering and process optimization for efficient L-tyrosine production from high-purity glucose syrup in Escherichia coli. Bioresource Technology, 425, 132306. https://doi.org/10.1016/j.biortech.2025.132306

8. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP). (2024). Assessment of the feed additive consisting of L-tyrosine for all animal species for the renewal of its authorisation (BCF Life Sciences). EFSA Journal, 22(7), e8845. https://doi.org/10.2903/j.efsa.2024.8845

9. Ajinomoto Health & Nutrition. (2023). Food-Grade Amino Acids – Purity, Safety, Efficacy. (Product information webpage). Retrieved from https://www.ajihealthandnutrition.com (Accessed 2025).

10. European Commission. (2014). Commission Regulation (EU) No 155/2014 of 19 February 2014, refusing to authorise certain health claims made on foods. Official Journal of the European Union, L50, 11–13. Available: http://data.europa.eu/eli/reg/2014/155/oj

11. U.S. Food and Drug Administration (FDA). (2020). 21 CFR §582.5920 – Tyrosine. In: Code of Federal Regulations Title 21, Part 582 (Substances Generally Recognized As Safe). Silver Spring, MD: FDA. Retrieved from https://www.ecfr.gov/current/title-21/section-582.5920

12. DC Fine Chemicals. (2022). Safety Data Sheet – L-Tyrosine, USP (CAS# 60-18-4). Revision 2.0, November 4, 2022. Available from: https://www.dcfinechemicals.com (accessed 2025).